Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
18.16+0.44 (+2.48%)
At close: 04:00PM EDT
18.16 0.00 (0.00%)
After hours: 04:05PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close17.72
Open17.42
Bid5.00 x 800
Ask21.39 x 1000
Day's Range17.51 - 18.29
52 Week Range14.04 - 25.63
Volume217,311
Avg. Volume373,147
Market Cap616.955M
Beta (5Y Monthly)1.06
PE Ratio (TTM)16.66
EPS (TTM)1.09
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
104% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for COLL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Collegium Pharmaceutical, Inc.
    COLL: What does Argus have to say about COLL?COLLEGIUM PHARMACEUTICAL INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • Simply Wall St.

    Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 6.8% CAGR over the last five years

    Collegium Pharmaceutical, Inc. ( NASDAQ:COLL ) shareholders might be concerned after seeing the share price drop 17% in...

  • InvestorPlace

    7 Micro-Cap Stocks to Take a Chance on Now

    Large-capitalization stocks have performed better than small-cap stocks over the last year. The overall markets are down 3.7% and core small-caps are down 14%, according to Morningstar.com. So, while momentum investors might choose to buy large-cap stocks for a market recovery, other investors might choose to buy overlooked small-caps that haven’t been bid up. But investors could also consider buying micro-cap stocks for overlooked value. Micro-cap stocks are those with a market capitalizations

  • GlobeNewswire

    Collegium to Participate in H.C. Wainwright Global Investment Conference

    STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022. Details of the event are as follows:Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET About Collegium Pharmaceutical, Inc.Collegium is a diversified, specialty p

Advertisement
Advertisement